Sustainable marine biotech

The medicine of tomorrow

Hofseth BioCare is processing marine raw material into products to enhance global health.

Reasons to invest
Our value

Research & Development

Hofseth BioCare is processing marine raw material into products to enhance global health.

Read more

Latest news

Featured

HBC product can claim to support healthy iron levels in the US

13.10.2020 - Vast market opportunities crystalize as Hofseth BioCare is able to claim that ProGo® containing Bioactive Peptides™ support healthy iron levels in the US market

Read more
Colla Go 1200x490
Strong approval of HBC products from health authorities
Ome Go
New study highlights the potential of OmeGo® as a prophylactic therapy for Asthma and COPD
Brilliant
Global retailer giant to sell HBC-product
Get notified
We care about your data privacy. Read about our privacy policy

Latest stock exchange notices

Stock Exhange Notices

NEW SHARE CAPITAL INCREASE REGISTERED

27.10.2020

MANDATORY NOTIFICATION OF TRADE

21.10.2020

NOTICE OF EXTRAORDINARY GENERAL MEETING

21.10.2020

HBC RECEIVES APPROVAL FROM HEALTH CANADA FOR QUALIFIED HEALTH CLAIMS FOCUSED ON MAINTAINING HEALTHY LEVELS OF FERRITIN AND HEMOGLOBIN AND THE BLOOD COMPONENTS REQUIRED FOR OXYGEN TRANSPORT

19.10.2020

Disclosure of large shareholding

16.10.2020

European webshops

UK Webshop

Shipping products inside the UK

German and Swiss webshop

Shipping products inside Germany and Switzerland

Norwegian webshop

Shipping products inside Norway